Kamada Ltd. (KMDA) Earnings Call Analysis

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings Reports

• Kamada (KMDA) Q1 2026: Plasma Center Revenue Pathway Opens, $8–10M Capacity Per Site Signals Expansion
  May 13, 2026
• Kamada (KMDA) Q4 2025: Dividend Payout Hits $14M as Organic Growth Drives 13% Revenue Guidance Lift
  March 11, 2026
• Kamada (KMDA) Q3 2025: Adjusted EBITDA Climbs 34% as Portfolio Diversifies Beyond Royalties
  November 10, 2025
• Kamada (KMDA) Q2 2025: EBITDA Margin Hits 25% as Portfolio Diversification Drives Profitable Growth
  August 13, 2025
• Kamada (KMDA) Q1 2025: EBITDA Jumps 54% as Portfolio Diversity Fuels Profitable Growth
  July 03, 2025

Browse all companies